Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.24 USD | +1.75% | -1.35% | +41.10% |
May. 10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
May. 09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.10% | 3.89B | |
+26.69% | 49.18B | |
+0.62% | 42.11B | |
+50.52% | 40.37B | |
-5.26% | 28.85B | |
+12.46% | 26.09B | |
-21.81% | 18.71B | |
+9.10% | 13.26B | |
+31.00% | 12.32B | |
-0.62% | 11.99B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Transcript : Crinetics Pharmaceuticals, Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-09-2019 02